Delivery Order SPE2DB22D9367-SPE2DB26FSU82
- Not listed
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $1,036.00 to DMS Pharmaceutical Group Inc. on August 29, 2025, for the supply of Zosyn 4.5 GM/100 ML in Galaxy Bag format (100 ML units). This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA under the SPE2DB program, a $500 million single-award contract valid through November 2026 that authorizes the issuance of firm fixed-price delivery orders for comprehensive...
- The Defense Logistics Agency awarded DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, a delivery order valued at $1,554.00 for ZOSYN 4.5 GM/100 ML Galaxy Bag 100ML on July 24, 2025. The contract utilizes firm fixed-price pricing with an ultimate completion date of August 14, 2025, and specifies Park Ridge, Illinois as the place of performance. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA, a...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $2,486.40 by the Defense Logistics Agency (DLA) on August 12, 2025, for the supply of Zosyn 4.5 GM/100 ML Galaxy Bag 100ML pharmaceutical product. This firm fixed-price delivery order, with an ultimate completion date of September 3, 2025, was issued without a set-aside designation. The contract represents a specific fulfillment under DMS...
- The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Zosyn 3.375 GM/50 ML Galaxy 50ML with a ceiling value of $1,351.60. The award, issued on August 20, 2025, with an ultimate completion date of September 11, 2025, utilizes a firm fixed-price contract type. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order by the Defense Logistics Agency (DLA) on September 29, 2025, for the supply of Zosyn 3.375 GM/50 ML Galaxy 50ML pharmaceutical products. This firm fixed-price delivery order carries a ceiling value of $1,612.38 with an ultimate completion date of October 21, 2025. The contract was awarded without a set-aside designation, allowing the vendor to...
- The U.S. Defense Logistics Agency (DLA) awarded a $1,078.70 firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the provision of a pharmaceutical product, ZOSYN 4.5 GM/100 ML GALAXY BAG 100ML, to support the medical supply needs of military health facilities. This delivery order is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group valued...
- The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for ZOSYN 3.375 GM/50 ML Galaxy 50ML with a ceiling value of $1,351.60. This delivery order, issued on August 6, 2025, with an ultimate completion date of August 27, 2025, utilizes firm fixed-price pricing and carries no set-aside designation. The award is issued under DMS Pharmaceutical Group's larger single-award...
- The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc. for ZOSYN 3.375 GM/50 ML Galaxy 50ML pharmaceutical product on September 2, 2025, with a ceiling value of $1,621.92. This firm fixed-price delivery order is scheduled for completion by September 23, 2025, and will be performed at the vendor's location in Park Ridge, Illinois. The contract was awarded without a set-aside designation, enabling the woman-owned small business to compete directly in the federal...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The award, valued at $1,078.70, is for the supply of a pharmaceutical product called ZOSYN 4.5 GM/100 ML GALAXY BAG 100ML. The delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. This...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, received a firm fixed-price delivery order from the Defense Logistics Agency (DLA) valued at $1,000.32 for ZOSYN 3.375 GM/50 ML Galaxy 50ML pharmaceutical product. The award, issued on July 21, 2025, with an ultimate completion date of August 11, 2025, represents a single delivery order with no set-aside designation. Performance will occur at the contractor's facility in Park...
- SPE2DB22D9367Indefinite Delivery Contract
- SPE2DB22D9367-SPE2DB26FSU82Delivery Order
The Defense Logistics Agency awarded a $4,982.40 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Zosyn 4.5 GM/100 ML Galaxy Bag 100ML. The delivery order, issued on October 27, 2025, with an ultimate completion date of November 18, 2025, carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. DMS Pharmaceutical Group is the sole contractor on this award with no identified subcontractors. This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a comprehensive $30.3 billion federal acquisition strategy. The underlying IDC, designated SPE2DR and awarded November 13, 2025, carries a $500 million ceiling value and extends through December 31, 2036, with a 30-month base period and three 30-month option periods. The PPV-G GEN V contract authorizes DLA to issue delivery orders for a full range of pharmaceutical products—including branded and generic prescription drugs, biologics, vaccines, and medical consumables—to support Department of Defense military healthcare facilities globally. DMS Pharmaceutical Group's established performance across numerous delivery orders demonstrates its critical role as a regional pharmaceutical supplier within the military medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.0k | 10/27/25 |